5290 Vertex
- 1810
- -1-0.06%
Vertex News
Analysts Have Conflicting Sentiments on These Technology Companies: Vertex (VERX), NeoGames (NGMS) and SEMrush Holdings (SEMR)
Needham: Vertex (VERX.US) Q4 performance was “steady” and raised the target price to $25
JMP Securities Reiterates Market Outperform on Vertex, Maintains $28 Price Target
Raymond James Adjusts Price Target on Vertex to $22 From $19, Keeps Outperform Rating
B of A Securities Upgrades Vertex to Neutral, Raises Price Target to $20
HC Wainwright & Co. Reiterates Buy on Vertex Energy, Maintains $15 Price Target
Oppenheimer Upgrades Vertex Energy to Outperform, Announces $14 Price Target
Analysts Offer Insights on Services Companies: Vertex Energy (VTNR) and Blink Charging Co (BLNK)
Oppenheimer Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX)
Analysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (TEVA), Vertex Pharmaceuticals (VRTX) and AbbVie (ABBV)
Raymond James Initiates Coverage On Vertex With Outperform Rating, Announces Price Target of $19
Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Siegfried Holding AG (OtherSGFEF) and Demant (OtherWILLF)
Vertex Pharmaceuticals (VRTX) Gets a Buy From BMO Capital
Bank of America Securities Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX)
SVB Securities Adjusts Price Target on Vertex Pharmaceuticals to $365 From $374, Maintains Outperform Rating
Vertex Energy Analyst Ratings
Northland Capital Markets Initiates Coverage On Vertex Energy With Outperform Rating, Announces Price Target of $15
Analysts' Opinions Are Mixed on These Healthcare Stocks: Cigna (CI), Illumina (ILMN) and Vertex Pharmaceuticals (VRTX)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Rocket Pharmaceuticals (RCKT)
SVB Leerink Maintains Outperform on Vertex Pharmaceuticals, Lowers Price Target to $365
No Data